MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0069544
Kopran Laboratories Limited - chemicals and materials in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹112.82 Cr
▲ 9% YoY
Net profit · FY 2025
₹20.99 Cr
Net margin 18.6%
EBITDA · FY 2025
₹33.74 Cr
EBITDA margin 29.9%
Authorised capital
₹8 Cr
Registered with MCA
Paid-up capital
₹5.3 Cr
Issued & subscribed
Open charges
₹52.24 Cr
Satisfied ₹45.24 Cr
Company age
40 yrs
Est. 1986
Employees · EPFO
59
Provident fund records
About Kopran Laboratories Limited
Data last updated:
Kopran Laboratories Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 12 August 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1986PLC040602. Its GSTIN is 27AAACK4406H3ZQ (Maharashtra). The company holds 5 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹5.3 Cr. It was formerly known as Kopran Laboratories Private Limited. It is led by directors including Varun Surendra Somani (Managing Director) and Surendran Nair.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Parijat House1076 Dr E Moses Rd Worli, Mumbai, Maharashtra, India – 400018.
As per the financials filed for FY 2025, the company reported a revenue of ₹112.82 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹20.99 Cr (net margin 18.6%) and EBITDA of ₹33.74 Cr (EBITDA margin 29.9%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 20% over five years.
The company has about 59 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Kopran. As per MCA filings, the company has open charges of ₹52.24 Cr and satisfied charges of ₹45.24 Cr on record. Court records list 9 cases involving the company, including 2 filed by the company and 7 filed against it; 2 cases are pending. The company has 7 deals on record (7 secondary share transfers); the latest was in March 2022. Its 10 peer companies in the Chemicals industry (Chemical Retail and Distribution, Healthcare Equipment Retail and Distribution) are compared by revenue, 5 larger and 5 smaller; the largest is Eastern Chemicals (Mumbai) Private Limited with revenue of ₹115.22 Cr.
Kopran Laboratories Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0069544). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kopranlaboratories.com.
Company Details of Kopran Laboratories Limited
CIN U24230MH1986PLC040602
Registration Number 040602
Incorporation Date 12 August 1986
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 24 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0069544
CIN History of Kopran Laboratories Limited
Kopran Laboratories has one previous CIN (Corporate Identification Number): U24230MH1986GAP040602. The current CIN is U24230MH1986PLC040602, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH1986PLC040602 | Current |
| U24230MH1986GAP040602 | Previous |
Key People
Varun Surendra Somani Managing Director Surendran Nair Director Adarsh Rajendra Somani Director Recognitions & Rankings of Kopran Laboratories
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressParijat House1076 Dr E Moses Rd Worli, Mumbai, Maharashtra, India – 400018
- IndustryChemicals and Materials, Chemical Distribution & Retail
Comprehensive company report
Kopran Laboratories Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Kopran Laboratories Limited
Kopran Laboratories operates one associated brand: Kopran. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical Company manufacturing a range of products | kopran.com |
Business Activity of Kopran Laboratories Limited
The main business activity of Kopran Laboratories is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Kopran Laboratories Limited FY 2025 filings available
Kopran Laboratories Limited reported revenue of ₹112.82 Cr (up 9% YoY) for FY 2025.
Revenue · FY 2025
₹112.82 Cr ▲ 9%
Net profit · FY 2025
₹20.99 Cr margin 18.6%
EBITDA · FY 2025
₹33.74 Cr margin 29.9%
Compounded Annual Growth Rate (CAGR) of Kopran Laboratories Limited
Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 27%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 50%
5 years · compounded
▲ 28%
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 9% growth in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Kopran Laboratories Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹33.74 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹20.99 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Kopran Laboratories Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 29.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 18.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kopran Laboratories are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Kopran Laboratories Limited
Kopran Laboratories has 5 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Surendran Nair | Director | 02 Aug 2024 | 2 Years 2 Months | Current |
| Adarsh Rajendra Somani | Director | 01 Sep 2015 | 11 Years 1 Months | Current |
| Rajiv Bafna Tejraj Also directs: Sarvamangal Marcantile Company Limited | Director | 02 Aug 2024 | 2 Years 2 Months | Current |
| Varun Surendra Somani Also directs: Kopran Limited, G Claridge and Company Limited, Sorabh Trading Private Limited and 5 more | Managing Director | 01 Sep 2015 | 11 Years 1 Months | Current |
| Namrata Varun Somani Also directs: Kopran Limited, Sorabh Trading Private Limited, Apurva Caplease and Finance Private Limited and 3 more | Director | 12 Feb 2015 | 11 Years 8 Months | Current |
Peer Comparison of Kopran Laboratories Limited
Kopran Laboratories Limited is compared with the companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution, Healthcare Equipment Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eastern Chemicals (Mumbai) Private Limited | ₹115.22 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Mumbai, Maharashtra, India |
| Marlecha's Scientific & Chemicals Private Limited | ₹114.97 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Chennai, Tamil Nadu, India |
| Rudrashri Lifesciences Private Limited | ₹114.31 Cr (FY 2024) | •••• | •••• | 3721.0% | •••• | Gandhidham, Gujarat, India |
| Shriganesh Kirana Private Limited | ₹114.24 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Delhi, India |
| Chemgems (India) Private Limited | ₹113.14 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Kolkata, West Bengal, India |
| Kopran Laboratories Limited this company | ₹112.82 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Mumbai, Maharashtra, India |
| Devi Pharma Wellness Private Limited | ₹112.45 Cr (FY 2025) | •••• | •••• | •••• | Thiruvananthapuram, Kerala, India | |
| Sonal Impex Limited | ₹111.74 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Khopoli, Maharashtra, India |
| K L B Instruments Company Private Limited | ₹111.47 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Delhi, India |
| Humsaa Exim Private Limited | ₹111.27 Cr (FY 2025) | •••• | •••• | -40.0% | •••• | Bangalore, Karnataka, India |
| P. Praful and Company Agency (India) Private Limited | ₹110.73 Cr (FY 2018) | •••• | •••• | 0.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Kopran Laboratories by revenue in the Chemicals industry (Chemical Retail and Distribution, Healthcare Equipment Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Kopran Laboratories Limited
Kopran Laboratories Limited is audited by KHANDELWAL JAIN & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KHANDELWAL JAIN & CO. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Kopran Laboratories Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kopran Laboratories Limited
Open charges
₹52.24 Cr
Satisfied charges
₹45.24 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Oct 2025 | Others | ₹2.38 Cr | Open |
| 24 Sep 2025 | Yes Bank Limited | ₹71.15 Lakh | Open |
| 31 Jul 2025 | Yes Bank Limited | ₹1.21 Cr | Open |
| 26 Sep 2024 | Others | ₹22 Cr | Open |
| 05 Aug 2024 | Others | ₹1.12 Cr | Open |
Total charge records: 28 View all charges
Deals & Funding of Kopran Laboratories Limited
Kopran Laboratories Limited has 7 deals on record (7 secondary share transfers); the latest was in March 2022.
Total deals
7
Secondary share transfers
7
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: Bigflex Enterprises Private Limited , 3 individuals Seller: 4 individuals |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: G.Claridge & Company Limited, 3 individuals Seller: Meenul Metallizing Private Limited , Claridge Investment Limited, 2 individuals |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: Meenul Metallizing Private Limited Seller: Sarvamangal Mercantile Co.Limited |
| Dec 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Debonair Publications Private Limited |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: Meenul Metallizing Private Limited , an individual Seller: Sarvamangal Mercantile Co.Limited |
Premium access
Full deal history
All 7 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Kopran Laboratories Limited
Kopran Laboratories Limited has 9 court cases on record: 2 filed by Kopran Laboratories, 7 filed against it. 2 cases are pending and 7 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Total cases
9
Filed by the company
2
Filed against the company
7
Pending
2
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 4 | 1 |
| District courts | 3 | 3 | 1 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Eko-Diagnostic Pvt Ltd | Disposed |
| District court, South Twenty Four Parganas, West Bengal | Civil suit | Filed against the company by Woodlands Multispeciality Hospital Limited | Disposed |
| High Court of Madhya Pradesh | Writ petition | Filed by the company against State of Madhya Pradesh | Pending |
| District court, Ahmedabad, Gujarat | Court case (SMST S) | Filed against the company by an individual | Pending |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed against the company by an individual | Disposed |
Premium access
Full case history
All 9 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Kopran Laboratories Limited
Kopran Laboratories Limited has a workforce of 59 employees as of Apr 08, 2024.
Employee count
59
Active EPFO establishments
1
Employee growth
-6.35%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Kopran Laboratories Limited
Kopran Laboratories Limited has 15 board changes on record since 2011: 5 appointments and 10 cessations. The latest: Rajiv Bafna Tejraj ceased to be Additional Director on 12 Sep 2024.
Charges
A charge registered on 23 Aug 2022 via Charge ID 100615026 with Others was fully satisfied on 20 Nov 2025.
Charges
A charge registered on 21 Jun 2022 via Charge ID 100593274 with Others was fully satisfied on 20 Nov 2025.
Charges
A charge registered on 31 Mar 2022 via Charge ID 100583917 with Others was fully satisfied on 20 Nov 2025.
Charges
A charge with Others amounted to Rs. 2.38 Cr with Charge ID 101187845 was registered on 29 Oct 2025.
AGM
Kopran Laboratories Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records.
Charges
A charge with Yes Bank Limited amounted to Rs. 0.71 Cr with Charge ID 101165324 was registered on 24 Sep 2025.
Charges
A charge with Yes Bank Limited amounted to Rs. 1.21 Cr with Charge ID 101136338 was registered on 31 Jul 2025.
Filing
Kopran Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 31 Aug 2017 via Charge ID 100152065 with Others was fully satisfied on 15 Feb 2025.
Charges
A charge with Others of Rs. 22.00 Cr registered on 26 Sep 2024 with Charge ID 100989267 was modified on 09 Dec 2024.
Charges
A charge registered on 26 Jul 2021 via Charge ID 100466068 with Yes Bank Limited was fully satisfied on 30 Sep 2024.
Charges
A charge registered on 20 Jul 2021 via Charge ID 100466066 with Yes Bank Limited was fully satisfied on 30 Sep 2024.
53 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Kopran Laboratories Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kopran Laboratories Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kopran Laboratories Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Kopran Laboratories Limited
Kopran Laboratories has 5 GST registrations: 4 active and 1 cancelled or inactive.
Total GSTINs
5
Active
4
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACK4406H3ZQ | Maharashtra | Active | 01 Sep 2017 |
| 27AAACK4406H4ZP | Maharashtra | Active | 12 Jun 2025 |
| 07AAACK4406H1ZU | Delhi | Active | 01 Jul 2017 |
| 19AAACK4406H1ZP | West Bengal | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kopran Laboratories Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kopran Laboratories Limited
Kopran Laboratories is an active public limited company based in Mumbai, Maharashtra, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 12 August 1986 (40+ years old) and is registered under CIN U24230MH1986PLC040602.
Kopran Laboratories reported revenue of ₹112.82 Cr for FY 2025 (up 9% YoY).
Kopran Laboratories has 5 current directors:
- Varun Surendra Somani - Managing Director
- Surendran Nair - Director
- Adarsh Rajendra Somani - Director
- Rajiv Bafna Tejraj - Director
- Namrata Varun Somani - Director
Kopran Laboratories reported a net profit of ₹20.99 Cr (net margin 18.6%) and EBITDA of ₹33.74 Cr (EBITDA margin 29.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Kopran Laboratories is 27% over three years and 20% over five years. In the latest year (FY 2025) revenue rose 9%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Kopran Laboratories is 27AAACK4406H3ZQ, registered in Maharashtra. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 27AAACK4406H4ZP (Maharashtra), 07AAACK4406H1ZU (Delhi), 19AAACK4406H1ZP (West Bengal).
The CIN (Corporate Identification Number) of Kopran Laboratories is U24230MH1986PLC040602. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kopran Laboratories has 9 court cases on record: 2 filed by the company and 7 filed against it. 2 are pending. Most are in the high courts.
Kopran Laboratories was incorporated on 12 August 1986, making it 40+ years old. It is registered with the Registrar of Companies, Mumbai.
Kopran Laboratories has 7 deals on record (7 secondary share transfers); the latest was in March 2022.
The peers of Kopran Laboratories by revenue are Eastern Chemicals (Mumbai) Private Limited, Marlecha's Scientific & Chemicals Private Limited, Rudrashri Lifesciences Private Limited, Shriganesh Kirana Private Limited, Chemgems (India) Private Limited and 5 more, all in the Chemicals industry (Chemical Retail and Distribution, Healthcare Equipment Retail and Distribution).